News
The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback